Teach-Back Educational Method On Diabetes Knowledge Level

Patient Empowerment Clinical Trial

Official title:

The Impact Of Teach-Back Educational Method On Diabetes Knowledge Level And Clinical Parameters In Type 2 Diabetes Patients Undergoing Insulin Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04509856
• Other study ID #: YaseminC
• Status: Completed
• Phase: N/A
• Start date: April 1, 2019
• Est. completion date: July 31, 2019

Study information

• Verified date: August 2020
• Source: Ataturk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It was aimed to research the effect of teach-back educational method on diabetes knowledge level and clinical parameters in type 2 diabetes patients undergoing insulin therapy. This is a randomized-controlled trial. Teach-back method will used for intervention group, routin diabetes education will used for control group. The primary outcome is diabetes knowledge levels (DKL), and secondary outcome is clinical patameters (fasting blood glucose, HbA1c, blood pressure). DKL and clinical parameters will measured and compared between two groups before and three months after the interventions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: July 31, 2019
• Est. primary completion date: June 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• To have Type 2 Diabetes

• To be over 18 years old

• Not have any barriers in understanding and speaking Turkish

• Who started insulin treatment for the first time

Exclusion Criteria:

• Patients with a diagnosis of dementia

• To have vision or hearing loss

Related Conditions & MeSH terms

• Patient Empowerment

Intervention

Behavioral:
• Teach-back educational method
In the teach-back method, after teaching new information to the patient, the patients were asked to explain that new information in their own words. Then the patients' knowledge and the adequateness of their explanations were determined. The patient should repeat the instructions in their own words. In this way, the healthcare professional can evaluate how the patient understands the information. If the patient repeated the information correctly, the teach-back phase for that information was completed, and progression for new information was resumed. However, if there was a deficiency or error in the information, it was corrected and repeated by the healthcare professional.

Locations

Country	Name	City	State
Turkey	Ataturk University Hospital	Erzurum

Sponsors (1)

Lead Sponsor	Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diabetes knowledge level (DKL)	The DKL will be measured through a self-structured questionnaire containing 11 items. The questionnaire contains three answers: "yes," "no," or "I do not know." The right answer will be accepted as two points, the wrong answer as zero points, and the "I do not know" answer will be accepted as one point. The total scores ranges from 0-22. Higher scores of the questionnaire indicates that the higher DKL.	3 months
Secondary	Fasting blood glucose	Fasting blood glucose in mg/dl	3 months
Secondary	HbA1c	HbA1c in %	3 months
Secondary	Blood pressure	Blood pressure in mmHG	3 months